Fosamax Cost in Texas 2026: Prices, Insurance, Medicaid, and Compounding Options

What Does Fosamax Actually Cost in Texas in 2026?

Generic alendronate 70 mg weekly runs about $15 per month at most Texas retail chains when you pay cash. That figure covers a 4-week supply of four tablets. Brand-name Fosamax from Merck carries a published list price of approximately $80 per month, though almost no patient pays that rate without some form of assistance or coverage.

The gap between $15 and $80 exists because generic alendronate entered the U.S. market in 2008, and Texas pharmacies have had well over a decade to drive generic prices down through competitive dispensing fees. A GoodRx or RxSaver coupon applied to the generic at chains such as H-E-B Pharmacy, CVS, or Walgreens in Texas typically lands between $9 and $18 depending on the specific location and quantity.

Brand vs. Generic: Is There a Clinical Difference?

No meaningful clinical difference exists between brand Fosamax and generic alendronate sodium for the standard osteoporosis indication. The FDA requires AB-rated generics to demonstrate bioequivalence within a 90% confidence interval of 80 to 125% for the 90th percentile pharmacokinetic parameters [1]. Alendronate generics hold AB ratings across all approved strengths.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027 women with low bone mass), demonstrated that alendronate reduced the risk of hip fractures by 51% and vertebral fractures by 47% over three years at 5 to 10 mg daily (equivalent to 35 to 70 mg weekly) compared to placebo (P<0.001) [2]. That evidence base applies equally to generics carrying the same active moiety and bioavailability profile.

Choosing brand Fosamax over generic at an $80 versus $15 price difference adds up to $780 per year with no additional fracture-risk benefit. Most Texas prescribers write for generic alendronate unless a patient has documented intolerance to a specific excipient in a generic formulation.

Texas Medicaid Coverage for Alendronate

Texas Medicaid does not cover alendronate for osteoporosis under the standard Medicaid fee-for-service program. The Texas Vendor Drug Program (VDP) formulary restricts alendronate coverage to the type 2 diabetes (T2D) indication under very specific clinical criteria, leaving the vast majority of patients who need it for osteoporosis or osteopenia without Medicaid reimbursement [3].

That restriction affects a significant population. The CDC reports that approximately 10.6% of Texas adults aged 65 and older have been diagnosed with osteoporosis, and a disproportionate share of low-income older Texans rely on Medicaid or dual Medicare-Medicaid coverage for their medications [4].

What Are Medicaid Patients' Options?

Texas Medicaid enrollees who need alendronate for osteoporosis have three realistic paths.

First, if the patient also carries a T2D diagnosis documented in the chart, the prescriber can submit prior authorization demonstrating that covered indication. That approach works only for patients with genuine comorbid T2D.

Second, patients dually eligible for Medicare and Medicaid (dual eligibles, also called "dual-eligible beneficiaries") receive their Part D drug benefit through Medicare, not Medicaid. Medicare Part D covers generic alendronate on virtually every plan formulary in Texas, typically in Tier 1 with a $0, $10 monthly copay. Patients unsure of their dual-eligibility status can call the Texas Health Information, Counseling and Advocacy Program (HICAP) at 1-800-252-9240.

Third, cash-pay at $15 per month through a discount program is often the simplest solution for Medicaid-only patients who lack dual eligibility.

Medicare Part D and Private Insurance Coverage in Texas

Most Texas Medicare Part D plans place generic alendronate on Tier 1 (preferred generic), which typically means a $0 to $10 monthly copay during the deductible-exempt phase. The CMS 2026 formulary comparison tool shows that all 20 standalone Part D plans operating in Texas as of January 2026 include at least one alendronate formulation on their formulary [5].

Private Commercial Insurance

Private insurers covering Texas employees, whether through the Texas Employees Group Benefits Program (ERS) or individual ACA marketplace plans, almost universally cover generic alendronate on Tier 1 or Tier 2. The standard step-therapy requirement, when present, asks only that the prescriber confirm the diagnosis of osteoporosis or osteopenia with a DEXA scan T-score of -1.0 or below. No prior authorization is required for the generic on most BlueCross BlueShield of Texas, Aetna, Cigna, and UnitedHealthcare commercial formularies as of 2026.

The American Association of Clinical Endocrinology (AACE) 2020 Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis state that "alendronate is a first-line pharmacological option based on the consistent demonstration of fracture risk reduction at the spine, hip, and non-vertebral sites" [6]. That first-line guideline status makes prior authorization denials uncommon on commercial plans in Texas.

What If Insurance Denies Coverage?

Alendronate denials typically stem from missing DEXA documentation or an outdated diagnosis code (use ICD-10 M81.0 for age-related osteoporosis without current pathological fracture). Sending the DEXA report and bone mineral density (BMD) T-score directly to the insurer with the prior authorization request resolves most denials on first appeal. If a denial persists, Texas Insurance Code Chapter 4201 grants patients the right to an independent review for osteoporosis drug appeals when medical necessity is disputed.

Compounded Alendronate in Texas: Legal Status and Practical Costs

Compounded alendronate is legal in Texas when prepared by a 503A pharmacy operating under a valid license from the Texas State Board of Pharmacy (TSBP). A 503A pharmacy compoundspatient-specific preparations based on individual prescriptions. It does not compound in bulk for office stock without a specific patient order, which separates it from 503B outsourcing facilities.

The TSBP requires that any compounded preparation of an FDA-approved drug like alendronate be based on a valid prescription for an identified individual patient and may not be commercially available in the exact form being compounded. Most compounded alendronate formulations in Texas are prepared as liquid suspensions or customized capsule strengths for patients with documented swallowing difficulties or specific dose requirements not met by commercially available 70 mg or 10 mg tablets.

Cost of Compounded Alendronate in Texas

Compounded alendronate from a 503A pharmacy in Texas can cost $0 per month in specific situations. Some compounding pharmacies absorb preparation fees for patients enrolled in bone-health programs through their prescribing clinic, or charge a flat dispensing fee covered by ancillary health benefits. Outside those arrangements, compounded alendronate typically runs $20, $60 per month depending on the formulation complexity and the pharmacy's fee schedule.

For most patients, compounded alendronate carries no clinical advantage over standard generic tablets, which cost less and have a more established stability profile. The main legitimate use cases are:

• Patients with Barrett esophagus or severe esophageal motility disorders who cannot tolerate oral bisphosphonate tablets and need a liquid formulation
• Pediatric patients with osteogenesis imperfecta requiring doses below 10 mg
• Patients with confirmed hypersensitivity to a specific inactive ingredient in all available generic tablets

If none of those conditions apply, a Texas prescriber should default to generic alendronate 70 mg weekly at approximately $15 per month.

FDA Oversight and Safety

The FDA does not review or approve compounded drugs for safety, efficacy, or manufacturing quality before dispensing. That means a compounded alendronate preparation lacks the same post-market safety surveillance network that the generic versions carry. Patients and prescribers should confirm that the compounding pharmacy holds current TSBP licensure, follows USP Chapter 795 standards for non-sterile preparations, and provides a certificate of analysis (CoA) for each batch.

Telehealth Prescribing of Alendronate in Texas

Alendronate can be prescribed via telehealth in Texas. The Texas Medical Board permits audio-video telemedicine encounters for initial osteoporosis consultations provided the prescriber holds a valid Texas medical license and the patient is located in Texas at the time of the encounter. Audio-only prescribing (phone without video) for Schedule-exempt drugs like alendronate is also permitted under the Texas Medical Board's 2023 telemedicine rules, though most Texas telehealth platforms use video for documentation quality.

A telehealth prescriber will typically order or review a DEXA scan before initiating alendronate. If the patient does not yet have a DEXA result, the prescriber can order one at a Texas imaging center. DEXA scans are covered by Medicare Part B for women age 65 and older and for younger patients with risk factors including glucocorticoid use, prior fragility fracture, or rheumatoid arthritis [5].

Telehealth visits for osteoporosis management in Texas generally cost $49, $99 out-of-pocket on platforms without insurance billing, or standard specialist copays when billed through insurance. HealthRX telehealth visits include a bone-health intake assessment and DEXA referral if indicated.

Discount Programs and Savings Cards for Fosamax in Texas

Several cost-reduction tools apply specifically in Texas for alendronate and Fosamax.

Merck Patient Assistance: Merck's branded Fosamax savings program has historically offered eligible commercially insured patients Fosamax for as little as $5 per month. Eligibility requires commercial (not government) insurance. Income criteria and program availability should be verified directly at Merck's patient assistance portal, as terms change annually.

GoodRx and Similar Discount Cards: GoodRx, RxSaver, and NeedyMeds coupons reduce the cash price of generic alendronate 70 mg (4 tablets) at Texas pharmacies to as low as $9 at some H-E-B and Walmart locations. These cards work at the point of sale and require no enrollment. They cannot be combined with insurance on the same prescription fill.

NeedyMeds Patient Assistance Programs: NeedyMeds.org lists pharmaceutical manufacturer programs for alendronate. For patients below 200% of the federal poverty level who are uninsured or underinsured, some programs provide free or reduced-cost branded product.

Texas HICAP: For Medicare beneficiaries, the Texas Health Information, Counseling and Advocacy Program offers free counseling on Part D plan selection. Choosing the right Part D plan for alendronate can reduce annual costs by more than $100 per year compared to a plan that places it on Tier 2 versus Tier 1.

340B Pharmacies: Federally qualified health centers (FQHCs) and other 340B-covered entities in Texas can dispense alendronate at 340B acquisition cost to eligible patients. The 340B price for alendronate is typically under $2 per month. Patients who receive care at an FQHC in Texas, such as CommuniCare Health Centers in San Antonio or Legacy Community Health in Houston, may qualify.

Choosing the Right Alendronate Dose in Texas

The FDA-approved dosing regimens for alendronate cover three main indications [7]:

• Postmenopausal osteoporosis treatment: 70 mg orally once weekly or 10 mg once daily
• Postmenopausal osteoporosis prevention: 35 mg once weekly or 5 mg once daily
• Glucocorticoid-induced osteoporosis: 5 mg once daily (10 mg once daily for postmenopausal women not on estrogen)
• Paget disease of bone: 40 mg once daily for six months

The once-weekly 70 mg tablet drives the large majority of Texas prescriptions because adherence data from post-marketing studies consistently show better rates with weekly than daily dosing. A 2004 trial (N=1,258) published in Osteoporosis International found that 12-month adherence was 61.7% for once-weekly alendronate versus 54.5% for once-daily dosing (P<0.05) [8].

Patients must take alendronate first thing in the morning on an empty stomach with 6, 8 oz of plain water and remain upright (sitting or standing) for at least 30 minutes before eating, drinking anything other than water, or taking other medications. Failure to follow these instructions increases the risk of esophageal irritation and reduces bioavailability, which is only about 0.6% even under ideal fasting conditions.

How Long Do Patients in Texas Stay on Alendronate?

The standard treatment duration before reassessment is three to five years. After five years of continuous alendronate therapy, the American Society for Bone and Mineral Research (ASBMR) 2016 Task Force recommends reassessment with a clinical fracture risk calculation and consideration of a "drug holiday" in patients who have achieved a BMD T-score above -2.5 at the hip and no high-risk features [9].

Patients at high fracture risk, defined as a FRAX 10-year hip fracture probability of 3% or greater or total fracture probability of 20% or greater, may benefit from continuing alendronate or transitioning to an alternative agent such as zoledronic acid 5 mg IV annually. The FIT Long-Term Extension (FLEX) trial (N=1,099) showed that women who continued alendronate for 10 years had a lower risk of clinical vertebral fractures than those who discontinued at five years, though hip fracture rates did not differ significantly between groups [10].

Bone turnover marker monitoring, specifically serum C-terminal telopeptide of type I collagen (CTX), can confirm that alendronate is suppressing bone resorption as expected. A CTX below 300 pg/mL on treatment suggests adequate adherence and response. Texas labs including Quest Diagnostics and LabCorp offer CTX testing, with costs typically $30, $80 cash-pay depending on ordering location.

Switching from Fosamax to Another Bisphosphonate in Texas

Some Texas patients ask about switching to zoledronic acid (Reclast) IV infusion, particularly those with persistent gastrointestinal side effects from oral alendronate or documented adherence problems. Zoledronic acid 5 mg is given once yearly by IV infusion and costs approximately $50, $100 at most Texas infusion centers after Medicare coverage, making annual cost roughly comparable to $15 per month oral generic alendronate.

The HORIZON Key Fracture Trial (N=7,765) showed zoledronic acid 5 mg annually reduced hip fracture risk by 41% and vertebral fracture risk by 70% over three years compared to placebo (P<0.001) [11]. Switching from oral alendronate to annual IV zoledronic acid is clinically appropriate and does not require a washout period; the next infusion can follow the last oral dose without interruption.

For patients who prefer oral therapy but cannot tolerate alendronate due to esophageal symptoms, oral risedronate 150 mg once monthly (Actonel) is an alternative with comparable fracture data and a slightly different GI tolerability profile. Generic risedronate costs approximately $25, $40 per month cash-pay in Texas.